Skip to search formSkip to main contentSkip to account menu

Biomarkers, Pharmacological

Known as: Pharmacological Biomarkers, Biological Markers, Pharmacological, Pharmacological Biological Markers 
Measurable biological parameters that serve for drug development, safety and dosing (DRUG MONITORING).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Obstructive lung disease, including asthma and chronic obstructive pulmonary disease (COPD), is characterized by heterogeneous… 
2017
2017
Background Up to 40% of patients with inflammatory arthritis on TNF-α inhibitor (TNFi) treatment fail to respond either due to… 
2016
2016
Effect of PM10, PM2.5, andPM1 on blood markers in a panel of elderly subjects. BACKGROUND: Systemic inflammation biomarkers have… 
2013
2013
Drug resistance can be defined as the failure of a drug to exert its expected effect on pharmacological biomarkers and is caused… 
2012
2012
Objective: Biomarkers uPA and PAI-1 are guideline recommended by ASCO, USA, and AGO, Germany, to be used in primary breast cancer… 
2010
2010
The present invention relates to a method for the diagnosis, early detection and / or risk stratification of a subject's… 
2007
2007
Worldwide, coronary heart disease (CHD) causes approximately one-third of all deaths in men and one-quarter of all deaths in… 
2005
2005
The present invention, diagnostic tools, their use in chemokine CCL18, and various methods as biomarker in example individual…